ConductScience.org, home

Trial · NCT06708299

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

NCT06708299, Phase 3, Recruiting, Cardiol Therapeutics Inc.

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3). Trials, record NCT06708299. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06708299

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
NCT number
NCT06708299
Status
Recruiting
Phases
Phase 3
Enrollment
110 participants, estimated
Lead sponsor
Cardiol Therapeutics Inc.
Conditions
Recurrent Pericarditis
Interventions
CardiolRx
First posted
2024-11-27
Last updated
2026-09-10

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarytime to pericarditis recurrence24 weekstime to a new episode of recurrent pericarditis\* from the timepoint of stopping the IL-1 blocker to Week 24
SecondaryProportions of patients free from a new episode of recurrent pericarditis24 weeksProportions of patients free from a new episode of recurrent pericarditis from the timepoint of stopping the IL-1 blocker to week 24
SecondaryPercentage of days with no or minimal pain24 weeksThe percentage of days with no or minimal pain as assessed by an NRS score ≤ 2 from the timepoint of stopping the IL-1 blocker to Visit 9 (Week 24)
Otherthe mean pain scoreweek 8, week 24\- the mean pain score using an 11-point NRS at Visit 6 (Week 8) and at Visit 9 (Week 24) (highest pain score recorded during the 7 days prior to Visit 6 and Visit 9)
Otherthe change in CRPweek 8, week 24\- the change in CRP from Visit 1 (Day 1) to Visit 6 (Week 8) and Visit 9 (Week 24)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
38471825BACKGROUND

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06708299

GET https://conductscience.org/api/trials/v1/NCT06708299/registered